Alexion presents findings of Soliris study - Bloomberg
BloombergResults of the study were presented Saturday at the annual meeting of the American Society of Nephrology in Denver; interim results of the study were ...Phase 2 Study of Eculizumab (Soliris(R)) in Patients with aHUS Resistant to